We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.
The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".
Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.
Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.
& Survival analysisi
Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.
SNRPB is not prognostic in Ovary Serous Cystadenocarcinoma (TCGA)
Stage:
Survival analysis
Current cut offi
Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.
:
Best expression cut offi
Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .
When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.
Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.
Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.
: N/A
P scorei
Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.
N/A
5-year survival highi
5-year survival for patients with higher expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
5-year survival lowi
5-year survival for patients with lower expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
TCGA RNA samplesi
RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .
Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.
Average TPM
324.9
Number of samples
349
Samples
Sample
Description
TPM
TCGA-59-2363-01A
0 years, female, asian, stage:Stage IIIA, alive, 165 days
1096.2
TCGA-29-1769-01A
0 years, female, white, stage:Stage IIIC, alive, 699 days
981.3
TCGA-13-0727-01A
0 years, female, white, stage:Stage IIIC, dead, 462 days
963.3
TCGA-25-1877-01A
0 years, female, white, stage:Stage IIIC, dead, 730 days
931.6
TCGA-24-2020-01A
0 years, female, white, stage:Stage IIIC, dead, 4624 days
822.4
TCGA-09-0369-01A
0 years, female, white, stage:Stage IIIC, dead, 1082 days
811.0
TCGA-04-1519-01A
0 years, female, stage:Stage IIIC, alive, 24 days
789.8
TCGA-04-1364-01A
0 years, female, white, stage:Stage IIIC, dead, 1024 days
770.9
TCGA-10-0938-01A
0 years, female, white, stage:Stage IIIC, dead, 636 days
769.1
TCGA-24-1850-01A
0 years, female, white, stage:Stage IIIC, alive, 168 days
741.4
TCGA-13-1492-01A
0 years, female, white, stage:Stage IIIC, dead, 3819 days
730.5
TCGA-23-2084-01A
0 years, female, white, stage:Stage IV, dead, 1516 days
727.7
TCGA-59-A5PD-01A
0 years, female, black or african american, stage:Stage IC, dead, 624 days
720.2
TCGA-23-1123-01A
0 years, female, white, stage:Stage IIIC, dead, 1018 days
690.1
TCGA-13-1497-01A
0 years, female, white, stage:Stage IIIC, alive, 3871 days
681.8
TCGA-29-1697-01A
0 years, female, white, stage:Stage IIIC, dead, 949 days
678.0
TCGA-29-1762-01A
0 years, female, white, stage:Stage IV, dead, 2634 days
662.3
TCGA-23-1024-01A
0 years, female, white, stage:Stage IV, alive, 468 days
653.2
TCGA-13-A5FT-01A
0 years, female, black or african american, stage:Stage IIIC, alive, 2143 days
633.0
TCGA-25-1323-01A
0 years, female, white, stage:Stage IIIC, dead, 395 days
630.9
TCGA-13-0766-01A
0 years, female, white, stage:Stage IIIC, dead, 1725 days
628.4
TCGA-23-1809-01A
0 years, female, white, stage:Stage IIC, alive, 16 days
619.1
TCGA-61-2009-01A
0 years, female, white, stage:Stage IIIC, alive, 1212 days
611.9
TCGA-29-2414-01A
0 years, female, white, stage:Stage IIIC, dead, 2621 days
609.7
TCGA-13-0920-01A
0 years, female, white, stage:Stage IIIC, dead, 1484 days
597.8
TCGA-13-0887-01A
0 years, female, white, stage:Stage IIIC, dead, 2028 days
594.0
TCGA-61-2102-01A
0 years, female, white, stage:Stage IIIC, dead, 197 days
593.6
TCGA-13-0725-01A
0 years, female, white, stage:Stage IIIC, dead, 377 days
589.3
TCGA-23-1110-01A
0 years, female, white, stage:Stage IIIC, alive, 1658 days
586.9
TCGA-25-1627-01A
0 years, female, white, stage:Stage IIIC, dead, 394 days
574.3
TCGA-13-0891-01A
0 years, female, white, stage:Stage IV, dead, 3128 days
558.6
TCGA-10-0933-01A
0 years, female, white, stage:Stage IIIC, dead, 446 days
546.8
TCGA-24-1474-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 676 days
546.5
TCGA-23-1109-01A
0 years, female, white, stage:Stage IIIC, dead, 1562 days
544.4
TCGA-29-1785-01A
0 years, female, white, stage:Stage IIIC, dead, 1104 days
535.8
TCGA-29-1784-01A
0 years, female, white, stage:Stage IIIC, alive, 163 days
530.6
TCGA-04-1347-01A
0 years, female, white, stage:Stage IV, alive, 1919 days
521.6
TCGA-13-1506-01A
0 years, female, white, stage:Stage IIIC, dead, 1039 days
514.6
TCGA-24-2290-01A
0 years, female, white, stage:Stage IIIC, dead, 1102 days
512.2
TCGA-25-2393-01A
0 years, female, white, stage:Stage IIIC, dead, 1157 days
508.2
TCGA-24-2027-01A
0 years, female, white, stage:Stage IV, dead, 3337 days
505.0
TCGA-10-0931-01A
0 years, female, white, stage:Stage IIIC, dead, 1000 days
495.2
TCGA-29-1774-01A
0 years, female, white, stage:Stage IIIC, alive, 527 days
487.3
TCGA-24-1567-01A
0 years, female, white, stage:Stage IIIB, dead, 524 days
483.8
TCGA-13-0916-01A
0 years, female, white, stage:Stage IIIC, alive, 1785 days
480.7
TCGA-13-0906-01A
0 years, female, white, stage:Stage IIIC, alive, 3619 days
480.1
TCGA-24-1843-01A
0 years, female, white, stage:Stage IIIC, alive, 106 days
475.1
TCGA-29-1695-01A
0 years, female, white, stage:Stage IIIC, dead, 1229 days
470.4
TCGA-04-1542-01A
0 years, female, white, stage:Stage IIIB, dead, 2561 days
469.7
TCGA-36-1574-01A
0 years, female, asian, stage:Stage IIIC, alive, 686 days
468.1
TCGA-59-2350-01A
0 years, female, stage:Stage IV, dead, 679 days
459.6
TCGA-25-1315-01A
0 years, female, white, stage:Stage IIIC, dead, 1583 days
459.3
TCGA-29-1776-01A
0 years, female, black or african american, stage:Stage IIIC, alive, 360 days
457.3
TCGA-24-1844-01A
0 years, female, white, stage:Stage IIIC, alive, 113 days
456.3
TCGA-30-1718-01A
0 years, female, white, stage:Stage IIIC, dead, 1579 days
451.8
TCGA-23-1107-01A
0 years, female, white, stage:Stage IV, dead, 9 days
450.5
TCGA-61-2002-01A
0 years, female, white, stage:Stage IIIC, alive, 547 days
450.2
TCGA-04-1365-01A
0 years, female, white, stage:Stage IIIB, alive, 947 days
449.4
TCGA-23-1113-01A
0 years, female, white, stage:Stage IV, dead, 949 days
448.8
TCGA-04-1331-01A
0 years, female, white, stage:Stage IIIC, dead, 1336 days
444.5
TCGA-13-0924-01A
0 years, female, white, stage:Stage IV, alive, 2614 days
444.0
TCGA-61-1919-01A
0 years, female, white, stage:Stage IIIC, dead, 1161 days
437.7
TCGA-61-1733-01A
0 years, female, white, stage:Stage IIIC, alive, 967 days
428.3
TCGA-61-1900-01A
0 years, female, black or african american, stage:Stage IIIB, alive, 176 days
427.1
TCGA-10-0937-01A
0 years, female, white, stage:Stage IIIC, dead, 608 days
426.0
TCGA-09-1669-01A
0 years, female, white, stage:Stage IIIA, alive, 928 days
425.0
TCGA-04-1651-01A
0 years, female, white, stage:Stage IIIC, dead, 1102 days
423.9
TCGA-24-1557-01A
0 years, female, white, stage:Stage IIIC, dead, 1213 days
423.0
TCGA-24-1418-01A
0 years, female, white, stage:Stage IIIC, alive, 243 days
421.4
TCGA-09-2051-01A
0 years, female, white, stage:Stage IIIC, alive, 1919 days
414.2
TCGA-29-1777-01A
0 years, female, white, stage:Stage IIIC, alive, 374 days
412.6
TCGA-29-2428-01A
0 years, female, white, stage:Stage IIIC, alive, 1372 days
409.3
TCGA-24-1464-01A
0 years, female, white, stage:Stage IIIC, dead, 379 days
404.6
TCGA-25-1628-01A
0 years, female, white, stage:Stage IIIC, dead, 627 days
404.4
TCGA-13-1407-01A
0 years, female, white, stage:Stage IIIC, alive, 2534 days
401.7
TCGA-13-1489-01A
0 years, female, white, stage:Stage IIIC, dead, 2553 days
400.9
TCGA-VG-A8LO-01A
0 years, female, black or african american, stage:Stage IV, dead, 24 days
400.3
TCGA-04-1356-01A
0 years, female, white, stage:Stage IIC, dead, 1499 days
400.1
TCGA-23-2078-01A
0 years, female, white, stage:Stage IIIC, alive, 2661 days
399.7
TCGA-04-1341-01A
0 years, female, white, stage:'--, alive, 33 days
396.7
TCGA-24-1424-01A
0 years, female, white, stage:Stage IIIC, alive, 183 days
390.2
TCGA-61-2098-01A
0 years, female, white, stage:Stage IIIC, alive, 1993 days
389.4
TCGA-24-2254-01A
0 years, female, white, stage:Stage IIIC, dead, 1736 days
388.4
TCGA-20-1683-01A
0 years, female, white, stage:Stage IIIC, alive, 772 days
387.7
TCGA-29-1701-01A
0 years, female, white, stage:Stage IIIC, dead, 515 days
387.1
TCGA-13-0911-01A
0 years, female, white, stage:Stage IV, dead, 1355 days
384.3
TCGA-23-1027-01A
0 years, female, white, stage:Stage IIIC, dead, 976 days
383.0
TCGA-25-1317-01A
0 years, female, white, stage:Stage IIIC, dead, 61 days
382.4
TCGA-23-1030-01A
0 years, female, white, stage:Stage IIIC, alive, 886 days
377.8
TCGA-29-1691-01A
0 years, female, white, stage:Stage IIIC, dead, 1470 days
375.3
TCGA-61-1918-01A
0 years, female, white, stage:Stage IV, dead, 479 days
371.7
TCGA-61-2003-01A
0 years, female, white, stage:Stage IIIC, alive, 122 days
371.3
TCGA-57-1583-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 346 days
370.7
TCGA-24-1103-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1646 days
370.5
TCGA-29-1770-01A
0 years, female, white, stage:Stage IIIC, alive, 741 days
370.1
TCGA-29-1688-01A
0 years, female, white, stage:Stage IIIC, dead, 2400 days
369.7
TCGA-61-1998-01A
0 years, female, white, stage:Stage IIIC, alive, 168 days
368.6
TCGA-09-0366-01A
0 years, female, white, stage:Stage IIIC, dead, 1757 days
368.6
TCGA-23-1111-01A
0 years, female, white, stage:Stage IIIC, alive, 98 days
368.2
TCGA-25-2404-01A
0 years, female, american indian or alaska native, stage:Stage IIIC, dead, 883 days
367.5
TCGA-04-1362-01A
0 years, female, white, stage:Stage IIC, dead, 1348 days
366.6
TCGA-13-0883-01A
0 years, female, white, stage:Stage IIIC, dead, 2097 days
366.5
TCGA-59-2352-01A
0 years, female, white, stage:Stage IIIC, dead, 286 days
365.3
TCGA-04-1514-01A
0 years, female, white, stage:Stage IIIA, dead, 1720 days
365.2
TCGA-61-2008-01A
0 years, female, asian, stage:Stage IIC, alive, 932 days
364.8
TCGA-09-1666-01A
0 years, female, white, stage:Stage IIIC, alive, 1752 days
364.4
TCGA-13-1507-01A
0 years, female, white, stage:Stage IIIC, dead, 1993 days
364.0
TCGA-13-0800-01A
0 years, female, white, stage:Stage IIIC, alive, 2661 days
360.8
TCGA-04-1343-01A
0 years, female, white, stage:Stage IV, dead, 361 days
359.3
TCGA-29-1703-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1815 days
358.0
TCGA-25-2400-01A
0 years, female, white, stage:Stage IIIC, dead, 1278 days
357.9
TCGA-57-1582-01A
0 years, female, white, stage:Stage IIIC, dead, 731 days
354.4
TCGA-13-1512-01A
0 years, female, white, stage:Stage IIIC, alive, 442 days
353.1
TCGA-29-1766-01A
0 years, female, white, stage:Stage IIIC, dead, 1199 days
352.3
TCGA-29-2425-01A
0 years, female, white, stage:Stage IIIC, alive, 1977 days
351.1
TCGA-13-0897-01A
0 years, female, white, stage:Stage IIIC, dead, 2182 days
349.1
TCGA-30-1860-01A
0 years, female, white, stage:Stage IIIC, dead, 1366 days
348.9
TCGA-13-0730-01A
0 years, female, white, stage:Stage IIIC, dead, 542 days
347.9
TCGA-61-1725-01A
0 years, female, white, stage:Stage IIIC, alive, 956 days
345.8
TCGA-61-2101-01A
0 years, female, white, stage:Stage IIIC, dead, 1688 days
344.6
TCGA-61-2109-01A
0 years, female, white, stage:Stage IIIC, dead, 629 days
344.5
TCGA-61-2113-01A
0 years, female, white, stage:Stage IIC, dead, 676 days
343.2
TCGA-25-1633-01A
0 years, female, white, stage:Stage IIIC, dead, 1891 days
342.8
TCGA-10-0927-01A
0 years, female, stage:Stage IIIC, dead, 2490 days
340.9
TCGA-13-0804-01A
0 years, female, white, stage:Stage IIIC, dead, 1073 days
339.6
TCGA-24-1544-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 820 days
336.8
TCGA-61-2000-01A
0 years, female, white, stage:Stage IIIC, alive, 441 days
336.0
TCGA-24-1846-01A
0 years, female, stage:Stage IIIC, alive, 133 days
334.8
TCGA-57-1994-01A
0 years, female, white, stage:'--, alive, 761 days
334.3
TCGA-24-1469-01A
0 years, female, white, stage:Stage IIIC, alive, 277 days
334.3
TCGA-57-1586-01A
0 years, female, white, stage:Stage IIIC, alive, 679 days
333.4
TCGA-61-1995-01A
0 years, female, white, stage:Stage IIIC, alive, 61 days
333.4
TCGA-25-2396-01A
0 years, female, white, stage:Stage IIIC, dead, 92 days
331.1
TCGA-31-1953-01A
0 years, female, asian, stage:Stage IIIC, alive, 204 days
330.9
TCGA-24-2023-01A
0 years, female, white, stage:Stage IIIA, dead, 1364 days
330.2
TCGA-31-1959-01A
0 years, female, white, stage:Stage IV, alive, 67 days
328.7
TCGA-04-1655-01A
0 years, female, white, stage:Stage IIIB, dead, 1380 days
327.1
TCGA-24-1423-01A
0 years, female, white, stage:Stage IIIC, alive, 190 days
326.9
TCGA-23-1118-01A
0 years, female, white, stage:Stage IIIC, alive, 2616 days
326.1
TCGA-13-1488-01A
0 years, female, white, stage:Stage IV, dead, 2154 days
322.7
TCGA-24-1842-01A
0 years, female, white, stage:Stage IIIC, alive, 253 days
322.4
TCGA-25-1316-01A
0 years, female, white, stage:Stage IIIC, dead, 1279 days
320.4
TCGA-24-1549-01A
0 years, female, white, stage:Stage IIIB, dead, 1721 days
320.3
TCGA-29-1711-01A
0 years, female, black or african american, stage:Stage IIIC, alive, 1053 days
318.4
TCGA-24-0966-01A
0 years, female, black or african american, stage:Stage IIIC, alive, 232 days
317.3
TCGA-36-1570-01A
0 years, female, white, stage:Stage IIIC, alive, 655 days
317.0
TCGA-24-1924-01A
0 years, female, white, stage:Stage IIIC, dead, 919 days
316.4
TCGA-25-1321-01A
0 years, female, white, stage:Stage IIIC, dead, 1033 days
315.9
TCGA-13-2060-01A
0 years, female, white, stage:Stage IV, alive, 2369 days
315.1
TCGA-23-1122-01A
0 years, female, white, stage:Stage IIIC, dead, 1189 days
313.6
TCGA-61-1738-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1089 days
313.6
TCGA-25-1313-01A
0 years, female, white, stage:Stage IV, dead, 820 days
313.1
TCGA-OY-A56Q-01A
0 years, female, black or african american, stage:Stage IIA, alive, 576 days
309.9
TCGA-09-0367-01A
0 years, female, native hawaiian or other pacific islander, stage:Stage IIIC, dead, 547 days
309.6
TCGA-31-1951-01A
0 years, female, white, stage:Stage IIIC, alive, 684 days
309.1
TCGA-61-1728-01A
0 years, female, white, stage:Stage IV, alive, 848 days
309.0
TCGA-61-2092-01A
0 years, female, white, stage:Stage IIIC, alive, 1573 days
308.9
TCGA-09-2054-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 637 days
304.6
TCGA-5X-AA5U-01A
0 years, female, black or african american, stage:Stage IIC, alive, 361 days
304.3
TCGA-24-2036-01A
0 years, female, white, stage:Stage IIIA, dead, 1947 days
303.3
TCGA-30-1866-01A
0 years, female, white, stage:Stage IV, dead, 1114 days
302.0
TCGA-25-1631-01A
0 years, female, white, stage:Stage IIIC, dead, 9 days
301.9
TCGA-30-1891-01A
0 years, female, white, stage:Stage IIIC, dead, 914 days
301.9
TCGA-25-2401-01A
0 years, female, white, stage:Stage IIIC, dead, 90 days
301.5
TCGA-36-1576-01A
0 years, female, stage:Stage IIIC, alive, 915 days
301.4
TCGA-20-0991-01A
0 years, female, white, stage:Stage IIB, alive, 797 days
300.5
TCGA-61-1724-01A
0 years, female, white, stage:Stage IIIC, dead, 637 days
300.5
TCGA-25-1326-01A
0 years, female, white, stage:Stage IIIC, dead, 1249 days
297.9
TCGA-23-1120-01A
0 years, female, white, stage:Stage IIIC, alive, 130 days
297.4
TCGA-24-1430-01A
0 years, female, white, stage:Stage IIIC, dead, 863 days
297.0
TCGA-61-1741-01A
0 years, female, white, stage:Stage IIIB, dead, 1024 days
296.3
TCGA-61-2012-01A
0 years, female, white, stage:Stage IIC, alive, 932 days
294.5
TCGA-29-1783-01A
0 years, female, white, stage:Stage IIIC, alive, 220 days
293.6
TCGA-30-1892-01A
0 years, female, white, stage:Stage IIIC, dead, 1484 days
291.9
TCGA-24-2281-01A
0 years, female, white, stage:Stage IIA, alive, 1357 days
289.7
TCGA-20-0987-01A
0 years, female, white, stage:Stage IIIC, dead, 701 days
288.8
TCGA-29-1705-01A
0 years, female, white, stage:Stage IIIC, dead, 555 days
288.6
TCGA-13-0923-01A
0 years, female, white, stage:Stage IIIC, alive, 2547 days
287.9
TCGA-30-1857-01A
0 years, female, white, stage:Stage IV, dead, 8 days
287.3
TCGA-WR-A838-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 304 days
287.0
TCGA-13-0797-01A
0 years, female, white, stage:Stage IIIC, alive, 2121 days
286.3
TCGA-09-1662-01A
0 years, female, white, stage:Stage IV, dead, 2717 days
286.2
TCGA-13-1509-01A
0 years, female, white, stage:Stage IV, alive, 2438 days
285.3
TCGA-25-1320-01A
0 years, female, white, stage:Stage IIIC, dead, 1155 days
285.0
TCGA-23-1023-01A
0 years, female, white, stage:Stage IIIC, alive, 1233 days
284.2
TCGA-31-1946-01A
0 years, female, stage:Stage IIIC, alive, 918 days
284.1
TCGA-24-2293-01A
0 years, female, white, stage:'--, dead, 506 days
283.6
TCGA-61-2104-01A
0 years, female, white, stage:Stage IIC, alive, 2338 days
283.1
TCGA-61-1737-01A
0 years, female, white, stage:Stage IV, alive, 1364 days
283.0
TCGA-31-1944-01A
0 years, female, white, stage:Stage IIIC, alive, 1386 days
282.8
TCGA-57-1993-01A
0 years, female, white, stage:Stage IIIC, alive, 763 days
279.9
TCGA-24-1847-01A
0 years, female, white, stage:Stage IV, alive, 343 days
279.3
TCGA-61-2097-01A
0 years, female, white, stage:Stage IIC, alive, 1844 days
279.1
TCGA-59-2348-01A
0 years, female, white, stage:Stage IIIC, alive, 5481 days
277.4
TCGA-24-1551-01A
0 years, female, white, stage:Stage IIIC, dead, 1579 days
276.9
TCGA-59-2351-01A
0 years, female, white, stage:Stage IIIC, alive, 3532 days
273.9
TCGA-09-1670-01A
0 years, female, white, stage:Stage IIIA, alive, 547 days
273.8
TCGA-24-2035-01A
0 years, female, white, stage:Stage IIIC, dead, 857 days
269.9
TCGA-09-0364-01A
0 years, female, white, stage:Stage IIC, dead, 887 days
269.5
TCGA-24-1560-01A
0 years, female, white, stage:Stage IIIC, dead, 1341 days
266.6
TCGA-13-0885-01A
0 years, female, white, stage:Stage IIIC, alive, 3388 days
266.2
TCGA-29-1761-01A
0 years, female, asian, stage:Stage IIIC, dead, 528 days
265.4
TCGA-29-1763-01A
0 years, female, black or african american, stage:Stage IIC, alive, 2032 days
264.4
TCGA-29-2427-01A
0 years, female, white, stage:Stage IIIC, alive, 1900 days
264.4
TCGA-25-2399-01A
0 years, female, white, stage:Stage IIIC, dead, 608 days
263.6
TCGA-09-2048-01A
0 years, female, white, stage:Stage IIIC, dead, 138 days
263.5
TCGA-29-A5NZ-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1088 days
263.4
TCGA-24-1558-01A
0 years, female, white, stage:Stage IIIC, dead, 594 days
263.1
TCGA-24-1930-01A
0 years, female, white, stage:Stage IIIC, dead, 2467 days
262.8
TCGA-25-1312-01A
0 years, female, white, stage:Stage IV, dead, 31 days
261.2
TCGA-25-1634-01A
0 years, female, white, stage:Stage IIIC, dead, 1091 days
261.2
TCGA-13-0724-01A
0 years, female, white, stage:Stage IV, dead, 83 days
261.2
TCGA-29-1768-01A
0 years, female, white, stage:Stage IV, dead, 952 days
261.0
TCGA-61-1911-01A
0 years, female, white, stage:Stage IIA, alive, 1293 days
261.0
TCGA-23-1022-01A
0 years, female, white, stage:Stage IIIC, dead, 1511 days
259.2
TCGA-25-1635-01A
0 years, female, white, stage:Stage IIIC, dead, 1583 days
259.0
TCGA-36-1571-01A
0 years, female, white, stage:Stage IIIB, dead, 695 days
258.8
TCGA-13-1510-01A
0 years, female, white, stage:Stage IIIC, dead, 1359 days
258.4
TCGA-24-2033-01A
0 years, female, white, stage:Stage IIIC, dead, 562 days
258.2
TCGA-25-1322-01A
0 years, female, white, stage:Stage IV, dead, 91 days
257.7
TCGA-61-1910-01A
0 years, female, white, stage:Stage IIC, alive, 1127 days
257.7
TCGA-24-2289-01A
0 years, female, white, stage:Stage IV, dead, 2049 days
257.6
TCGA-13-1487-01A
0 years, female, white, stage:Stage IV, dead, 681 days
255.3
TCGA-24-1105-01A
0 years, female, white, stage:Stage IIIC, dead, 1442 days
251.4
TCGA-13-0795-01A
0 years, female, white, stage:Stage IIIC, dead, 619 days
249.3
TCGA-30-1714-01A
0 years, female, white, stage:Stage IV, dead, 1158 days
248.6
TCGA-36-1577-01A
0 years, female, asian, stage:Stage IIC, alive, 783 days
248.3
TCGA-61-1914-01A
0 years, female, stage:Stage IIIC, alive, 1722 days
246.8
TCGA-25-1626-01A
0 years, female, white, stage:Stage IIIC, dead, 518 days
246.5
TCGA-13-1499-01A
0 years, female, white, stage:Stage IIIC, alive, 3500 days
246.1
TCGA-13-1409-01A
0 years, female, white, stage:Stage IIIC, dead, 1742 days
246.0
TCGA-24-1435-01A
0 years, female, white, stage:Stage IIIC, dead, 1324 days
244.1
TCGA-57-1584-01A
0 years, female, white, stage:Stage IIIC, alive, 643 days
243.3
TCGA-59-2354-01A
0 years, female, white, stage:Stage IIIC, dead, 1046 days
243.1
TCGA-24-1562-01A
0 years, female, white, stage:Stage IIIC, dead, 1384 days
242.4
TCGA-23-2077-01A
0 years, female, white, stage:Stage IIIC, alive, 3525 days
242.3
TCGA-13-1408-01A
0 years, female, white, stage:Stage IIIC, dead, 1680 days
240.2
TCGA-04-1350-01A
0 years, female, white, stage:Stage IIIC, dead, 1946 days
239.7
TCGA-13-1505-01A
0 years, female, white, stage:Stage IIIC, alive, 1998 days
239.5
TCGA-13-1405-01A
0 years, female, white, stage:Stage IV, dead, 868 days
237.8
TCGA-13-1485-01A
0 years, female, white, stage:Stage IV, dead, 629 days
237.8
TCGA-24-1550-01A
0 years, female, white, stage:Stage IIIC, dead, 1249 days
237.4
TCGA-24-2288-01A
0 years, female, white, stage:Stage IIIC, dead, 25 days
235.9
TCGA-61-2110-01A
0 years, female, white, stage:Stage IIIC, dead, 1354 days
235.1
TCGA-13-1511-01A
0 years, female, asian, stage:Stage IV, dead, 1650 days
234.7
TCGA-13-1495-01A
0 years, female, white, stage:Stage IIIC, dead, 2749 days
234.0
TCGA-31-1950-01A
0 years, female, white, stage:Stage IIIC, alive, 571 days
232.6
TCGA-36-1568-01A
0 years, female, stage:Stage IIIC, alive, 875 days
231.5
TCGA-29-1696-01A
0 years, female, white, stage:Stage IIIC, dead, 1032 days
230.9
TCGA-24-0968-01A
0 years, female, white, stage:Stage IIIC, dead, 598 days
230.1
TCGA-25-1319-01A
0 years, female, white, stage:Stage IIIC, dead, 1977 days
229.1
TCGA-24-1413-01A
0 years, female, white, stage:Stage IIIC, alive, 192 days
228.3
TCGA-04-1530-01A
0 years, female, white, stage:Stage IIIC, dead, 3622 days
225.8
TCGA-24-1563-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1451 days
225.8
TCGA-20-1682-01A
0 years, female, white, stage:Stage IIIC, alive, 837 days
225.2
TCGA-36-1581-01A
0 years, female, white, stage:Stage IIC, alive, 751 days
223.5
TCGA-24-2261-01A
0 years, female, white, stage:Stage IIIC, dead, 24 days
221.8
TCGA-13-0726-01A
0 years, female, white, stage:Stage IIIC, dead, 949 days
221.7
TCGA-24-1553-01A
0 years, female, white, stage:Stage IIIB, dead, 1767 days
220.4
TCGA-36-1569-01A
0 years, female, white, stage:Stage IIIC, alive, 885 days
219.8
TCGA-25-1630-01A
0 years, female, white, stage:Stage IIIC, dead, 1162 days
216.6
TCGA-24-1616-01A
0 years, female, white, stage:Stage IIIC, dead, 1163 days
216.4
TCGA-25-1870-01A
0 years, female, white, stage:Stage IIIC, dead, 455 days
214.4
TCGA-24-1428-01A
0 years, female, white, stage:Stage IIIC, alive, 529 days
212.9
TCGA-13-1496-01A
0 years, female, white, stage:Stage IIIC, dead, 129 days
212.5
TCGA-30-1862-01A
0 years, female, white, stage:Stage IV, dead, 186 days
212.2
TCGA-24-2024-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1769 days
211.9
TCGA-23-1116-01A
0 years, female, white, stage:Stage IIIC, dead, 592 days
210.7
TCGA-25-1632-01A
0 years, female, white, stage:Stage IV, dead, 1799 days
209.7
TCGA-25-2409-01A
0 years, female, white, stage:Stage IV, dead, 821 days
209.7
TCGA-13-1410-01A
0 years, female, white, stage:Stage IV, alive, 2464 days
209.5
TCGA-13-1483-01A
0 years, female, white, stage:Stage IIIC, dead, 895 days
207.5
TCGA-24-1425-01A
0 years, female, white, stage:Stage IIIC, alive, 181 days
207.5
TCGA-09-2045-01A
0 years, female, asian, stage:Stage IV, dead, 1069 days
206.0
TCGA-57-1585-01A
0 years, female, white, stage:Stage IIIC, dead, 53 days
206.0
TCGA-30-1861-01A
0 years, female, white, stage:Stage IIIC, dead, 1058 days
205.1
TCGA-24-2271-01A
0 years, female, asian, stage:Stage IIIC, dead, 962 days
204.7
TCGA-24-1604-01A
0 years, female, white, stage:Stage IIIC, dead, 2688 days
203.9
TCGA-61-2111-01A
0 years, female, white, stage:Stage IV, alive, 3825 days
201.7
TCGA-24-2267-01A
0 years, female, white, stage:Stage IIB, dead, 1446 days
200.7
TCGA-24-1104-01A
0 years, female, white, stage:Stage IV, dead, 1933 days
200.1
TCGA-24-1923-01A
0 years, female, white, stage:Stage IIIC, dead, 690 days
199.4
TCGA-25-2398-01A
0 years, female, white, stage:Stage IIIC, dead, 1369 days
199.1
TCGA-24-2026-01A
0 years, female, white, stage:Stage IIIC, dead, 1059 days
199.0
TCGA-61-1907-01A
0 years, female, white, stage:Stage IIIC, alive, 952 days
198.3
TCGA-13-1498-01A
0 years, female, white, stage:Stage IIIC, dead, 2012 days
192.5
TCGA-24-1603-01A
0 years, female, white, stage:Stage IIIB, dead, 2742 days
191.3
TCGA-25-1623-01A
0 years, female, white, stage:Stage IV, dead, 565 days
188.3
TCGA-24-1552-01A
0 years, female, white, stage:Stage IIIC, dead, 1259 days
188.1
TCGA-04-1536-01A
0 years, female, black or african american, stage:Stage IV, dead, 885 days
186.6
TCGA-24-1416-01A
0 years, female, white, stage:Stage IV, alive, 194 days
186.4
TCGA-36-1580-01A
0 years, female, stage:Stage IIIC, dead, 737 days
186.2
TCGA-29-1693-01A
0 years, female, white, stage:Stage IIIC, alive, 3096 days
185.4
TCGA-24-2280-01A
0 years, female, white, stage:Stage IIIC, alive, 2143 days
184.3
TCGA-13-0888-01A
0 years, female, white, stage:Stage IIIC, dead, 2811 days
182.0
TCGA-29-1710-01A
0 years, female, white, stage:Stage IIIC, dead, 951 days
181.1
TCGA-24-1431-01A
0 years, female, white, stage:Stage IIIC, dead, 583 days
179.7
TCGA-30-1853-01A
0 years, female, white, stage:Stage IIIC, dead, 1103 days
179.0
TCGA-24-2297-01A
0 years, female, white, stage:Stage IIIC, dead, 1699 days
178.6
TCGA-31-1956-01A
0 years, female, white, stage:Stage IIIB, alive, 1342 days
178.2
TCGA-09-1673-01A
0 years, female, white, stage:Stage IV, alive, 92 days
177.9
TCGA-29-1694-01A
0 years, female, white, stage:Stage IIIC, dead, 1187 days
177.4
TCGA-04-1361-01A
0 years, female, white, stage:Stage IIIB, alive, 989 days
176.7
TCGA-13-0720-01A
0 years, female, white, stage:Stage IIIC, dead, 1355 days
176.6
TCGA-24-1419-01A
0 years, female, white, stage:Stage IIIC, alive, 239 days
176.2
TCGA-20-1686-01A
0 years, female, white, stage:Stage IIIC, alive, 89 days
175.7
TCGA-24-0982-01A
0 years, female, white, stage:Stage IIIC, dead, 679 days
175.7
TCGA-24-1434-01A
0 years, female, white, stage:Stage IIIC, dead, 568 days
174.5
TCGA-24-1565-01A
0 years, female, white, stage:Stage IIIC, dead, 312 days
173.2
TCGA-29-1781-01A
0 years, female, white, stage:Stage IIIC, alive, 255 days
172.0
TCGA-13-0762-01A
0 years, female, white, stage:Stage IIIC, alive, 3400 days
170.5
TCGA-10-0928-01A
0 years, female, white, stage:Stage IIIC, dead, 563 days
169.1
TCGA-13-0886-01A
0 years, female, white, stage:Stage IIIC, alive, 4665 days
166.9
TCGA-04-1648-01A
0 years, female, white, stage:Stage IIIC, dead, 871 days
165.0
TCGA-29-1690-01A
0 years, female, white, stage:Stage IIIC, dead, 1448 days
164.5
TCGA-13-1477-01A
0 years, female, white, stage:Stage IV, dead, 1662 days
163.7
TCGA-13-1404-01A
0 years, female, white, stage:Stage IIIC, alive, 2469 days
159.4
TCGA-25-2042-01A
0 years, female, american indian or alaska native, stage:Stage IIIC, dead, 396 days
158.1
TCGA-13-0768-01A
0 years, female, white, stage:Stage IIIC, dead, 1784 days
157.1
TCGA-24-1422-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 23 days
155.0
TCGA-13-1403-01A
0 years, female, white, stage:Stage IIIC, dead, 2345 days
153.2
TCGA-20-1687-01A
0 years, female, white, stage:Stage IV, alive, 81 days
151.5
TCGA-59-2355-01A
0 years, female, white, stage:Stage IV, dead, 65 days
149.7
TCGA-13-1411-01A
0 years, female, white, stage:Stage IIIC, dead, 531 days
149.6
TCGA-24-2298-01A
0 years, female, white, stage:Stage IIIC, dead, 1620 days
149.0
TCGA-25-1329-01A
0 years, female, white, stage:Stage IIIC, dead, 457 days
148.8
TCGA-24-1427-01A
0 years, female, stage:Stage IIIC, alive, 147 days
146.3
TCGA-13-0765-01A
0 years, female, white, stage:Stage IIIC, dead, 1389 days
145.1
TCGA-04-1338-01A
0 years, female, white, stage:Stage IIIC, alive, 1418 days
144.6
TCGA-24-1845-01A
0 years, female, white, stage:Stage IIIC, alive, 116 days
141.9
TCGA-24-1928-01A
0 years, female, white, stage:Stage IIIC, dead, 336 days
138.1
TCGA-24-2038-01A
0 years, female, white, stage:Stage IIIA, dead, 1354 days
136.5
TCGA-24-1467-01A
0 years, female, white, stage:Stage IIIC, dead, 3224 days
136.0
TCGA-25-1318-01A
0 years, female, white, stage:Stage IIIC, dead, 1064 days
133.7
TCGA-29-1778-01A
0 years, female, white, stage:Stage IIIC, alive, 454 days
130.5
TCGA-25-2392-01A
0 years, female, white, stage:Stage IV, dead, 31 days
129.7
TCGA-04-1332-01A
0 years, female, white, stage:Stage IIIC, dead, 1247 days
129.3
TCGA-13-0714-01A
0 years, female, white, stage:Stage IV, dead, 189 days
125.5
TCGA-25-1328-01A
0 years, female, white, stage:Stage IIIC, dead, 2009 days
124.6
TCGA-24-1426-01A
0 years, female, white, stage:Stage IIIC, alive, 163 days
123.2
TCGA-61-1721-01A
0 years, female, white, stage:Stage IV, alive, 338 days
122.0
TCGA-24-1417-01A
0 years, female, white, stage:Stage IV, alive, 238 days
119.0
TCGA-61-2088-01A
0 years, female, white, stage:Stage IIIC, alive, 145 days
117.6
TCGA-23-1119-01A
0 years, female, white, stage:Stage IIIC, alive, 3953 days
110.5
TCGA-23-1028-01A
0 years, female, white, stage:Stage IIIC, alive, 1503 days
108.5
TCGA-13-1501-01A
0 years, female, white, stage:Stage IV, dead, 1314 days
108.0
TCGA-24-1546-01A
0 years, female, white, stage:Stage IIIC, dead, 1955 days
101.0
TCGA-24-1471-01A
0 years, female, white, stage:Stage IIIC, alive, 36 days
95.2
TCGA-24-0979-01A
0 years, female, white, stage:Stage IV, dead, 1264 days
The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.
The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".
Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.
Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.
& Survival analysisi
Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.
SNRPB is not prognostic in Ovary Serous Cystadenocarcinoma (validation)
Stage:
Survival analysis
Current cut offi
Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.
:
Best expression cut offi
Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .
When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.
Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.
Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.
: N/A
P scorei
Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.
N/A
5-year survival highi
5-year survival for patients with higher expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
5-year survival lowi
5-year survival for patients with lower expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
TCGA RNA samplesi
RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .
Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.
Average TPM
251.7
Number of samples
81
Samples
Sample
Description
TPM
DO46528
0 years, female, NA, stage:III, alive, 6139 days
946.7
DO46388
0 years, female, NA, stage:III, dead, 413 days
643.4
DO46463
0 years, female, NA, stage:III, dead, 2451 days
551.1
DO46352
0 years, female, NA, stage:III, dead, 677 days
524.7
DO46360
0 years, female, NA, stage:IV, dead, 1759 days
508.9
DO46453
0 years, female, NA, stage:III, dead, 3294 days
484.9
DO46362
0 years, female, NA, stage:III, dead, 1639 days
409.3
DO46560
0 years, female, NA, stage:IV, dead, 286 days
402.2
DO46356
0 years, female, NA, stage:III, dead, 911 days
400.4
DO46576
0 years, female, NA, stage:III, alive, 133 days
386.8
DO46329
0 years, female, NA, stage:III, dead, 1699 days
367.7
DO46538
0 years, female, NA, stage:III, dead, 1527 days
365.7
DO46412
0 years, female, NA, stage:III, dead, 597 days
365.2
DO46438
0 years, female, NA, stage:IV, alive, 2227 days
365.1
DO46568
0 years, female, NA, stage:III, dead, 320 days
347.0
DO46458
0 years, female, NA, stage:IV, alive, 3787 days
326.8
DO46378
0 years, female, NA, stage:III, alive, 843 days
326.0
DO46586
0 years, female, NA, stage:III, dead, 1019 days
313.0
DO46333
0 years, female, NA, stage:III, dead, 359 days
305.1
DO46581
0 years, female, NA, stage:III, dead, 408 days
304.1
DO46597
0 years, female, NA, stage:III, dead, 393 days
298.1
DO46364
0 years, female, NA, stage:III, dead, 806 days
296.0
DO46376
0 years, female, NA, stage:III, dead, 1430 days
295.9
DO46468
0 years, female, NA, stage:III, alive, 2776 days
274.8
DO46394
0 years, female, NA, stage:IV, dead, 1039 days
272.5
DO46368
0 years, female, NA, stage:III, dead, 2879 days
270.1
DO46436
0 years, female, NA, stage:III, alive, 3193 days
268.3
DO46523
0 years, female, NA, stage:IV, alive, 1873 days
264.1
DO46533
0 years, female, NA, stage:III, alive, 3667 days
262.5
DO46513
0 years, female, NA, stage:IV, dead, 1883 days
261.6
DO46346
0 years, female, NA, stage:III, dead, 1187 days
258.3
DO46396
0 years, female, NA, stage:III, dead, 583 days
257.0
DO46338
0 years, female, NA, stage:III, dead, 596 days
253.2
DO46591
0 years, female, NA, stage:III, dead, 195 days
249.2
DO46344
0 years, female, NA, stage:III, dead, 642 days
243.5
DO46408
0 years, female, NA, stage:III, dead, 489 days
240.4
DO46432
0 years, female, NA, stage:III, alive, 2218 days
240.1
DO46602
0 years, female, NA, stage:III, dead, 205 days
238.7
DO46372
0 years, female, NA, stage:III, dead, 1326 days
237.3
DO46380
0 years, female, NA, stage:III, dead, 1423 days
227.6
DO46588
0 years, female, NA, stage:III, dead, 438 days
223.2
DO46330
0 years, female, NA, stage:III, dead, 684 days
221.3
DO46443
0 years, female, NA, stage:III, dead, 2464 days
217.0
DO46325
0 years, female, NA, stage:III, dead, 477 days
208.3
DO46334
0 years, female, NA, stage:III, dead, 496 days
205.3
DO46370
0 years, female, NA, stage:III, dead, 1727 days
204.7
DO46384
0 years, female, NA, stage:III, dead, 614 days
204.1
DO46551
0 years, female, NA, stage:III, dead, 1055 days
203.5
DO46400
0 years, female, NA, stage:III, dead, 719 days
201.5
DO46328
0 years, female, NA, stage:III, dead, 972 days
199.8
DO46354
0 years, female, NA, stage:III, dead, 843 days
199.4
DO46546
0 years, female, NA, stage:III, dead, 1889 days
195.8
DO46404
0 years, female, NA, stage:III, dead, 690 days
194.5
DO46342
0 years, female, NA, stage:III, dead, 1398 days
180.0
DO46348
0 years, female, NA, stage:IV, dead, 287 days
173.3
DO46358
0 years, female, NA, stage:III, dead, 423 days
172.7
DO46386
0 years, female, NA, stage:III, dead, 1162 days
169.2
DO46340
0 years, female, NA, stage:III, dead, 616 days
168.0
DO46374
0 years, female, NA, stage:III, dead, 1409 days
167.3
DO46327
0 years, female, NA, stage:III, dead, 184 days
164.8
DO46336
0 years, female, NA, stage:IV, dead, 664 days
157.3
DO46571
0 years, female, NA, stage:III, dead, 243 days
157.1
DO46402
0 years, female, NA, stage:III, dead, 511 days
155.7
DO46392
0 years, female, NA, stage:III, dead, 628 days
155.6
DO46332
0 years, female, NA, stage:III, dead, 689 days
155.4
DO46448
0 years, female, NA, stage:III, dead, 654 days
149.0
DO46350
0 years, female, NA, stage:III, dead, 886 days
143.7
DO46428
0 years, female, NA, stage:IV, alive, 2644 days
143.4
DO46493
0 years, female, NA, stage:IV, alive, 839 days
142.5
DO46508
0 years, female, NA, stage:III, dead, 2101 days
142.0
DO46566
0 years, female, NA, stage:III, dead, 673 days
137.8
DO46398
0 years, female, NA, stage:III, alive, 437 days
137.4
DO46382
0 years, female, NA, stage:IV, dead, 311 days
135.4
DO46366
0 years, female, NA, stage:III, dead, 2054 days
123.2
DO46518
0 years, female, NA, stage:III, alive, 2960 days
107.6
DO46326
0 years, female, NA, stage:III, dead, 701 days
104.3
DO46390
0 years, female, NA, stage:III, dead, 374 days
90.6
DO46611
0 years, female, NA, stage:III, dead, 734 days
85.1
DO46331
0 years, female, NA, stage:III, dead, 612 days
83.6
DO46606
0 years, female, NA, stage:III, alive, 804 days
82.0
DO46561
0 years, female, NA, stage:III, dead, 195 days
79.5
Show allShow less
OVARY SEROUS CYSTADENOCARCINOMA - Protein relative expression (CPTAC)
Number of samples
108
Samples
Sample ID
Sample type
nRPX
256ac9f5-1e19-44b4-92fb-fef3fc_D2
Tumor
1.7
91b287fd-eadb-442d-abcd-20b741_D2
Tumor
1.4
3a380577-c134-47ba-a1ce-988d7c_D2
Tumor
1.4
af95e2c6-25c4-4ab8-bf06-3e15ff_D2
Tumor
1.3
2563cb02-d58a-4286-8634-7502cd_D2
Tumor
1.3
347e379b-77c0-4dd3-aa25-18c9d1_D2
Tumor
1.3
76e77c6b-c80e-4391-bdbb-e1dcea_D2
Tumor
1.3
2433b136-fc7b-4cea-b958-bc6efb_D2
Tumor
1.2
5c3971ee-87c7-4dff-b66e-f18892_D2
Tumor
1.2
2f901c90-617e-46da-9fac-d68369_D2
Tumor
1.2
2dc28da8-7ff1-4b9b-b5bd-17cc25_D2
Tumor
1.1
2b4ce90c-8036-4207-ac3e-54a76f_D2
Tumor
1.1
3dcf8b3c-c0c5-4dfa-9543-5d30fb_D2
Tumor
1.1
627e6e36-3dca-4ee5-9755-6f3510_D2
Tumor
1.0
49bd51fe-48a1-4828-b66e-b30c38_D2
Tumor
1.0
15524912-685a-47ce-a824-567848_D2
Tumor
1.0
a03d1103-b809-42c4-ad5c-5aff58_D2
Tumor
1.0
9e0d47e0-f633-468b-b82b-4d752d_D2
Tumor
1.0
9c8e78bf-b03e-4ba0-9909-5ff070_D2
Tumor
1.0
ce1e5dfc-2ef1-4633-af93-5ea4d9_D2
Tumor
1.0
eb0a53df-7620-4024-8d2d-051142_D2
Tumor
1.0
f6c215ea-5381-4521-bb61-be8e97_D2
Tumor
1.0
9b90eb78-2f50-4aeb-b010-d642f9_D2
Tumor
1.0
79b60f32-6cca-4cb6-9a1e-22a3ac_D2
Tumor
0.9
3d3e1888-d67e-4c69-ba83-112d0f_D2
Tumor
0.9
161317f3-1a39-438e-af45-cd2502_D2
Tumor
0.9
41d0619e-b299-42e2-ac32-29e784_D2
Tumor
0.9
2115808b-6a0d-49bc-a8d7-b83bde_D2
Tumor
0.9
fe83e13f-9754-403b-8f74-d6caf8_D2
Tumor
0.9
7d953d1d-84b6-4ecd-b1d7-1ed865_D2
Tumor
0.9
8234f8ea-bdbd-45b0-bd0b-16f1e7_D2
Tumor
0.9
cfd76f9a-ce60-4ec7-8e6b-a8fc31_D3
Tumor
0.8
80873a0c-1f40-4d51-bab1-3f2071_D2
Tumor
0.8
4ccb249a-6722-491e-97e9-e3b4e7_D2
Tumor
0.8
10c2d629-0287-4511-ac25-f29031_D2
Tumor
0.8
3946a96c-e0ae-442f-83b4-a9350e_D2
Tumor
0.8
27f3ca2d-a86f-479d-8e7e-5307c7_D2
Tumor
0.8
51a4ce2f-4166-4c6b-a7e0-942d0a_D2
Tumor
0.8
a8853382-b726-4ce8-98d5-ca89df_D2
Tumor
0.8
d38f40fb-dd78-43b2-8b7b-4b6977_D2
Tumor
0.7
d109a3c0-350e-47f5-bda0-61899c_D2
Tumor
0.7
51c1c79e-5a8e-4b0a-bf92-1c0cab_D2
Tumor
0.7
5ea22f5e-307b-491d-801f-8b7fa6_D2
Tumor
0.7
8d78194e-fbef-4819-a7b5-b73ae9_D2
Tumor
0.7
558333b0-ea23-4303-9e3c-4932b1_D2
Tumor
0.7
318d53c3-216b-4de1-a098-77d6dd_D2
Tumor
0.7
340a3769-3031-41ae-bb08-a2f696_D2
Normal
0.7
42d860a3-8a0c-4c44-a09a-9ad8cf_D2
Tumor
0.7
1a10c200-3895-4648-b951-94f99f_D2
Tumor
0.7
28d0abdb-f682-4bd3-9425-a9c508_D2
Tumor
0.7
1772e913-f62e-446a-8cf3-720348_D2
Tumor
0.6
1b2ab076-c72f-4bbe-b9f9-657d24_D2
Tumor
0.6
e9d416e7-f661-400a-896e-388545_D2
Tumor
0.6
285fed94-1495-448e-879b-b55de9_D2
Tumor
0.6
e3ebe010-cd31-4b5d-8fcb-b7103b_D2
Tumor
0.6
c17b0ff9-9057-4848-a0cc-abb25f_D2
Tumor
0.6
08296da7-70ea-44df-8646-09f2cc_D2
Tumor
0.5
46c73531-f531-4ec3-97fe-b39d9d_D2
Tumor
0.5
1c9145ad-1981-4871-aa7e-8b11de_D2
Tumor
0.5
7069e990-4a4e-4984-a66d-4d835a_D2
Tumor
0.5
74a45e5a-a35a-4c60-a4b4-f3f5ea_D2
Tumor
0.5
1de8d3d8-fc0e-4be0-8aa7-127c7b_D2
Tumor
0.5
bd266bdd-12e4-42cb-9c49-911bfc_D2
Tumor
0.5
eb3f3494-7057-4afe-b212-e6e9a3_D2
Tumor
0.5
e7b656bf-3c34-4ba1-bdf3-c7eefe_D2
Tumor
0.4
6530147a-efe9-4df6-ac2f-03ece3_D2
Tumor
0.4
fbb41c94-aabd-49cc-90b2-882c3e_D2
Tumor
0.4
927f0958-db5a-4bc5-92b7-2a3695_D2
Tumor
0.4
efc971f8-54c5-4531-a792-705ecf_D2
Tumor
0.4
52c064a7-78d9-4a1a-85b4-27c6d1_D2
Tumor
0.4
9a7a86d3-bbf2-4d36-941d-c75c03_D1_D2
Tumor
0.4
35a345a4-e954-4c81-ae3f-7797cd_D2
Tumor
0.3
3490835c-c004-45ed-91f3-7c206f_D2
Tumor
0.3
2224c03f-b7b1-4368-887e-2b4cdf_D2
Tumor
0.3
a3a26070-fb84-406a-8280-d555e6_D2
Normal
0.2
3e746bea-ed68-40e6-b348-6ddf08_D2
Normal
0.2
d4791079-c826-4fc7-9d9b-ee20ba_D2
Tumor
0.2
0cc794c3-5bf5-4621-b238-58a0f6_D2
Tumor
0.2
62f5840e-6cd7-4200-b651-645e53_D2
Tumor
0.2
b9c1f22e-61f7-45ed-b3b4-5094c7_D2
Normal
0.2
0c87932d-b6fd-4eb5-b86a-a34d07_D2
Tumor
0.1
e6850782-fd2a-4c53-b682-1852fe_D2
Tumor
0.1
05387aad-2a1f-42c2-8d6f-950598_D3
Tumor
0.1
69d552be-7cb2-4bb4-b602-a27b3e_D2
Tumor
0.1
61f76fe6-a1c6-41b8-bdc2-2f9209_D2
Normal
0.0
1abbcb28-f221-4cd4-8c01-37b9bb_D1_D2
Normal
0.0
7c7ce2d7-6c8a-424e-8e6c-d14ad1_D2
Tumor
0.0
6319b36b-533c-4e86-8e12-80552e_D3
Tumor
0.0
092af714-b97a-457c-b0e9-8c20e8_D2
Normal
-0.1
50997c44-1c8b-4d34-b535-4a6cc2_D2
Tumor
-0.1
a65d8e76-640f-4341-a561-afbb57_D2
Normal
-0.1
7edfd606-4bee-4529-9fec-1ca7f0_D2
Normal
-0.2
1556af7e-c2ae-4fce-9aae-87c459_D1_D2
Normal
-0.2
21efd60f-6a31-4b98-9477-16a905_D2
Normal
-0.2
1db5574d-aca7-403c-8100-6e705f_D2
Normal
-0.2
2b73e01c-347a-4dae-a71d-752aeb_D2
Normal
-0.2
e23eb014-69c1-460a-b9d4-9786c8_D2
Normal
-0.3
31c15e30-21d4-4843-bd4a-9cd0d8_D2
Normal
-0.3
8e17b45e-6a06-4e4e-913d-7b1edb_D2
Tumor
-0.4
685ec3c2-e67a-40d3-9eb3-aa01c9_D1_D2
Normal
-0.5
994f9b8e-46cb-413f-8ec8-2c2fed_D2
Normal
-0.6
a583d3ff-8165-43e9-b764-23b7ef_D1_D2
Normal
-0.6
0745488e-0bfb-4d1f-8228-dedf76_D1_D2
Normal
-0.7
3fbf076a-824b-4eac-b6dc-bf5e59_D2
Normal
-0.7
6e209757-a7f4-45af-b5f3-2ebc02_D2
Normal
-0.7
b22659b9-e12c-4725-a7db-a833de_D1_D2
Normal
-0.8
8ed739dd-ae0f-4881-971a-db3cf4_D1_D2
Normal
-0.9
2ed8beb2-bc63-4bad-b5fe-1916a0_D2
Tumor
-1.0
Show allShow less
OVARIAN CANCER - Protein expressioni
A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here.
Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.
Antibody stainingi
Antibody staining in the annotated cell types in the current human tissue is reported as not detected, low, medium, or high, based on conventional immunohistochemistry profiling in selected tissues. This score is based on the combination of the staining intensity and fraction of stained cells.
Each image is clickable and will lead to virtual microscopy that enables deeper exploration of all samples and also displays staining intensity scores, fraction scores and subcellular localization as well as patient and tissue information for each sample.